People

Found 32,852 articles

• 

  What Brent Saunders Thinks About a Possible Allergan Breakup

  10/20/2017

  Allergan is a good example of how many mergers and acquisitions over a very short period of time created a large, international company.

• Jaguar Health Subsidiary Napo Pharmaceuticals Establishes Scientific Advisory Boards for Planned Follow-on Indications for Mytesi, Napo's FDA-approved Human Prescription Drug

  10/20/2017

  Jaguar Health announced today that its wholly-owned subsidiary, Napo Pharmaceuticals, has established a scientific advisory board for each potential follow-on indication currently planned for Mytesi (crofelemer), Napo's FDA-approved, first-in-class anti-secretory human prescription drug.

• Doug Berthiaume to Retire As Chairman of the Board of Waters Corporation; Chris O'Connell Elected As New Chairman

  10/20/2017

  Waters Corporation announced today that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017.

• Median Technologies Appoints Vivian Wang As General Manager, China and Takashi Hayashi As Managing Director, Japan

  10/20/2017

  Median Technologies, The Imaging Phenomics Company today announces the appointment of Vivian Wang as General Manager, China and the appointment of Takashi Hayashi as Managing Director, Japan.

• Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer

  10/19/2017

  Cellect announced today that it has nominated Dr. Ronit Bakimer-Kleiner as Chief Development Officer replacing Dr. Yaron Pereg.  

• Corbus Pharma Appoints Paris Panayiotopoulos To Its Board Of Directors

  10/19/2017

  Corbus Pharmaceuticals, a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that it has appointed Mr. Paris Panayiotopoulos to its Board of Directors.

• eClinicalHealth Announces The Appointment Of Mark Paul As Head Of The Company's US Operations

  10/19/2017

  eClinicalHealth Limited, a cloud-based eClinical technology company, announces that it has named Mark Paul as head of eClinicalHealth’s US operations.

• Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices

  10/19/2017

  Bamforth is a senior exec with thirty years of biologics experience including CDMO leadership.

• Spectral Announces Retirement of Chief Financial Officer

  10/19/2017

  Spectral Medical announced that Tony Businskas will be retiring as the Executive Vice President and CFO of the Company on January 31, 2018, after 12 years of service to the Company.

• Tetra Bio-Pharma Continues Forward into the Veterinary Ophthalmology Market by Entering into an Agreement with Drs. Cullen and Webb

  10/19/2017

  Tetra Bio-Pharma Continues Forward into the Veterinary Ophthalmology Market by Entering into an Agreement with Drs. Cullen and Webb

• Second Sight Announces Appointments Of Frank Vandeputte As Vice President And General Manager, EMEA And Asia Pacific; Gregoire Cosendai As Vice President, Clinical Affairs

  10/19/2017

  Second Sight Medical Products announced the appointment of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific, where he will lead all commercial activities for the Company outside of North America.

• 3D Signatures Announces Changes to Its Board of Directors and Audit Committee

  10/19/2017

  3D Signatures added Keith Cassidy to the Company’s board of directors and to the Company’s audit committee, effective immediately.

• Freenome Announces Formation of Scientific Advisory Board

  10/19/2017

  Freenome announced the formation of its Scientific Advisory Board (SAB) comprised of leading experts in genomics and machine learning.

• Millstone Medical Welcomes Microbiologist to Headquarter Sterile Packaging Facility

  10/19/2017

    [18-October-2017]   FALL RIVER, Mass., Oct. 18, 2017 /PRNewswire/ -- Millstone Medical announced today the addition of on-site Microbiologist, Joshua Browning, to their Fall River sterile packaging facility. Joshua previously served as a Quality Control Analyst, Microbiology at Nanotherapeutics where he executed facility process qualifications and validations of ISO 7 and ISO 8 cleanro

• Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications

  10/19/2017

  Bayer is proud to announce today the appointment of Jennifer Brendel to VP of Communications for the company's Consumer Health Division in the U.S.

• Former Eli Lilly Exec Emerges as the Front-Runner for Top HHS Job

  10/18/2017

  Alex Azar worked at the Department of Health and Human Services under President George W. Bush before joining drugmaker Eli Lilly.

• Pernix Therapeutics Announces Planned Departure of Chief Financial Officer

  10/18/2017

  Graham Miao, Ph.D., President and Chief CFO, will leave the Company at the end of the year in order to pursue other opportunities.

• 

  3 More Moderna R&D Execs Quietly Step Down

  10/18/2017

  So this year, Moderna has lost the head of its cancer division, its top lawyer, and its chief business officer.

• CRF Health Appoints Key Executives Following Business Growth And Investment

  10/18/2017

  CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has made two senior appointments to support the continuing growth of the global business.

• Bayer Appoints Brenda L. Raphael Senior Vice President and General Manager of Therapeutics Business Unit for Consumer Health

  10/18/2017

  Bayer today announced the appointment of Brenda L. Raphael as Senior VP and General Manager of the Therapeutics Business Unit of Consumer Health Commercial Operations North America, effective October 30, 2017.